Aktiespot

Sanofi India Limited (SANOFI INDIA LTD) aksje

SANOFI.BO

Stengt
₹3,183.75+3.30 (+0.10%)
Laster graf...

SANOFI INDIA LTD

Åpning3,206.90
Høy3,220.00
Lav3,175.00
Volum1.16k
P/E23.67
Markedsverdi73.32B
52-ukers høy6,399.95
52-ukers lav3,057.60
Gj.sn. volum2.1k
Utbytte7.55%
Beta0.17
EPS134.53

Om Sanofi India Limited (SANOFI INDIA LTD) aksje

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company offers pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, anti-infectives, and central nervous system under the Lantus, Toujeo, Soliqua, Clexane, Amaryl, Cardace, Lasix, Lasilactone, Glimepiride, Cetapin, Targocid, Frisium, Targocio, Combiflam, DePura, Allegra, Baralgan, BUSCOGAST, Dulcoflex, Enterogermina, Novalgin, and Avil brands through independent distributors. It also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited operates as a subsidiary of Hoechst GmbH.

Selskapsinformasjon

Børs: BSE (BSE)
Sektor: Sundhed
Industri: Lægemiddelproducenter – Generelt
Adresse:
Sanofi House
400072 Mumbai, India
Telefon: + 91 22 2803 2000

Analytikernes aksjeanbefalinger

Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.

Laveste kursmål
3,700.00
16.2%
Gjennomsnittlig kursmål
4,579.00
43.8%
Median kursmål
4,487.00
40.9%
Høyeste kursmål
5,550.00
74.3%

Andre ser også på: